| Date Filed | Type | Description |
| 03/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2020 |
4
| Dorton Katina (Director) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Granted 27,994 options to buy
@ $16.96, valued at
$474.8k
|
|
| 12/04/2020 |
3
| Dorton Katina (Director) has filed a Form 3 on Pandion Therapeutics, Inc. |
| 11/23/2020 |
4
| Becker Daniel J. (Director) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Bought 197,716 shares
@ $15.12, valued at
$3M
|
|
| 11/19/2020 |
4
| Becker Daniel J. (Director) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Bought 2,170 shares
@ $14.63, valued at
$31.7k
Bought 13,027 shares
@ $15.43, valued at
$201k
Bought 14,197 shares
@ $15.26, valued at
$216.6k
|
|
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2020 |
4
| Mutz Mitchell (10% Owner) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Granted 13,997 options to buy
@ $18, valued at
$251.9k
|
|
| 07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2020 |
4
| Carroll Jill (10% Owner) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Converted 1,538,724 shares
@ $0
Converted 348,469 shares
@ $0
Bought 361,111 shares
@ $18, valued at
$6.5M
Converted 7,846,554 preferred shares
@ $0
Converted 1,776,980 preferred shares
@ $0
Granted 13,997 options to buy
@ $18, valued at
$251.9k
|
|
| 07/21/2020 |
4
| JDRF T1D Fund LLC (10% Owner) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Converted 204,313 shares
@ $0
Converted 222,020 shares
@ $0
Converted 948,225 options to buy
@ $0
Converted 1,132,170 preferred shares
@ $0 |
|
| 07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2020 |
4
| Carlo Rizzuto (Director) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Granted 13,997 options to buy
@ $18, valued at
$251.9k
|
|
| 07/21/2020 |
4
| Kakkar Rahul (CEO) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Converted 21,133 shares
@ $0
Bought 14,000 shares
@ $18, valued at
$252k
Granted 27,181 options to buy
@ $18, valued at
$489.3k
Granted 221,067 options to buy
@ $18, valued at
$4M
Granted 100,493 options to buy
@ $18, valued at
$1.8M
Converted 107,768 preferred shares
@ $0 |
|
| 07/21/2020 |
4
| Sundy John (Chief Medical Officer) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Bought 2,000 shares
@ $18, valued at
$36k
Granted 145,420 options to buy
@ $18, valued at
$2.6M
|
|
| 07/21/2020 |
4
| Stagliano Nancy (Director) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Converted 15,004 shares
@ $0
Bought 1,000 shares
@ $18, valued at
$18k
Granted 3,674 options to buy
@ $18, valued at
$66.1k
Granted 13,997 options to buy
@ $18, valued at
$251.9k
Converted 28,620 preferred shares
@ $0
Converted 47,898 preferred shares
@ $0 |
|
| 07/21/2020 |
4
| Viney Joanne L. (See Remarks) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Converted 21,133 shares
@ $0
Bought 1,200 shares
@ $18, valued at
$21.6k
Granted 56,637 options to buy
@ $18, valued at
$1M
Granted 58,239 options to buy
@ $18, valued at
$1M
Converted 107,768 preferred shares
@ $0 |
|
| 07/21/2020 |
4
| Frail Donald (Director) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Converted 11,741 shares
@ $0
Bought 10,000 shares
@ $18, valued at
$180k
Granted 4,750 options to buy
@ $18, valued at
$85.5k
Granted 13,997 options to buy
@ $18, valued at
$251.9k
Converted 59,872 preferred shares
@ $0 |
|
| 07/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2020 |
4
| Freedman Edward D. (COO) has filed a Form 4 on Pandion Therapeutics, Inc.|
Txns:
| Converted 2,348 shares
@ $0
Granted 2,112 options to buy
@ $18, valued at
$38k
Granted 53,131 options to buy
@ $18, valued at
$956.4k
Granted 660 options to buy
@ $18, valued at
$11.9k
Converted 11,974 preferred shares
@ $0 |
|
| 07/16/2020 |
3
| Access Industries Holdings LLC (10% Owner) has filed a Form 3 on Pandion Therapeutics, Inc. |
|